These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3753749)

  • 1. Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome.
    Auwerx J; De Keyser L; Bouillon R; De Moor P
    Nephron; 1986; 42(3):231-5. PubMed ID: 3753749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D metabolites in childhood nephrotic syndrome.
    Grymonprez A; Proesmans W; Van Dyck M; Jans I; Goos G; Bouillon R
    Pediatr Nephrol; 1995 Jun; 9(3):278-81. PubMed ID: 7632510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D and calcium metabolism in children with nephrotic syndrome of normal renal function.
    Huang JP; Bai KM; Wang BL
    Chin Med J (Engl); 1992 Oct; 105(10):828-32. PubMed ID: 1291200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D metabolism in nephrotic rats.
    Chan YL; Mason RS; Parmentier M; Savdie E; Lissner D; Posen S
    Kidney Int; 1983 Sep; 24(3):336-41. PubMed ID: 6606068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium and vitamin D homeostasis in patients with heavy proteinuria.
    Saha H
    Clin Nephrol; 1994 May; 41(5):290-6. PubMed ID: 8050209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome.
    Lambert PW; De Oreo PB; Fu IY; Kaetzel DM; von Ahn K; Hollis BW; Roos BA
    Metab Bone Dis Relat Res; 1982; 4(1):7-15. PubMed ID: 6289039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function.
    Goldstein DA; Haldimann B; Sherman D; Norman AW; Massry SG
    J Clin Endocrinol Metab; 1981 Jan; 52(1):116-21. PubMed ID: 6969729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
    Lin CY; Huang TP
    Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium and vitamin-D metabolism in nephrotic syndrome.
    Alon U; Chan JC
    Int J Pediatr Nephrol; 1983 Jun; 4(2):115-8. PubMed ID: 6688609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of metabolic bone disease in adult patients with the nephrotic syndrome and normal renal function.
    Korkor A; Schwartz J; Bergfeld M; Teitelbaum S; Avioli L; Klahr S; Slatopolsky E
    J Clin Endocrinol Metab; 1983 Mar; 56(3):496-500. PubMed ID: 6822651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and vitamin-D-binding protein kinetics in patients treated with continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Heaf JG
    Perit Dial Int; 1989; 9(4):281-4. PubMed ID: 2488382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanisms for the selective action of vitamin D analogs.
    Dusso AS; Negrea L; Gunawardhana S; Lopez-Hilker S; Finch J; Mori T; Nishii Y; Slatopolsky E; Brown AJ
    Endocrinology; 1991 Apr; 128(4):1687-92. PubMed ID: 2004595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between free and total 1,25-dihydroxyvitamin D in conditions of modified binding.
    van Hoof HJ; de Sévaux RG; van Baelen H; Swinkels LM; Klipping C; Ross HA; Sweep CG
    Eur J Endocrinol; 2001 Apr; 144(4):391-6. PubMed ID: 11275949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal dogs and dogs with acute and chronic renal failure.
    Gerber B; Hässig M; Reusch CE
    Am J Vet Res; 2003 Sep; 64(9):1161-6. PubMed ID: 13677396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium and vitamin D metabolism in children with nephrotic syndrome.
    Freundlich M; Bourgoignie JJ; Zilleruelo G; Abitbol C; Canterbury JM; Strauss J
    J Pediatr; 1986 Mar; 108(3):383-7. PubMed ID: 3485195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of vitamin D-binding protein and vitamin D metabolite loss in children on continuous ambulatory peritoneal dialysis.
    Chen WT; Yamaoka K; Nakajima S; Tanaka Y; Yamamoto T; Satomura K; Okada S; Seino Y
    Bone Miner; 1992 Jun; 17(3):389-98. PubMed ID: 1623332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
    Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
    Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteomalacia and hyperparathyroid bone disease in patients with nephrotic syndrome.
    Malluche HH; Goldstein DA; Massry SG
    J Clin Invest; 1979 Mar; 63(3):494-500. PubMed ID: 429568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.